374 related articles for article (PubMed ID: 9454814)
21. Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate.
Hasanein P; Parviz M; Keshavarz M; Javanmardi K; Allahtavakoli M; Ghaseminejad M
Eur J Pharmacol; 2007 Jan; 554(2-3):123-7. PubMed ID: 17107671
[TBL] [Abstract][Full Text] [Related]
22. N-methyl-D-aspartate receptor antagonist MK-801 suppresses glial pro-inflammatory cytokine expression in morphine-tolerant rats.
Liu CH; Cherng CH; Lin SL; Yeh CC; Wu CT; Tai YH; Wong CS
Pharmacol Biochem Behav; 2011 Sep; 99(3):371-80. PubMed ID: 21624390
[TBL] [Abstract][Full Text] [Related]
23. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes.
Tiseo PJ; Cheng J; Pasternak GW; Inturrisi CE
J Pharmacol Exp Ther; 1994 Jan; 268(1):195-201. PubMed ID: 8301558
[TBL] [Abstract][Full Text] [Related]
24. Secondary heat, but not mechanical, hyperalgesia induced by subcutaneous injection of bee venom in the conscious rat: effect of systemic MK-801, a non-competitive NMDA receptor antagonist.
Chen HS; Chen J
Eur J Pain; 2000; 4(4):389-401. PubMed ID: 11124011
[TBL] [Abstract][Full Text] [Related]
25. Involvement of N-methyl-d-aspartate (NMDA) receptors in a rat model of visceral hypersensitivity.
Gaudreau GA; Plourde V
Behav Brain Res; 2004 Apr; 150(1-2):185-9. PubMed ID: 15033291
[TBL] [Abstract][Full Text] [Related]
26. Sex differences in hyperalgesia during morphine infusion: effect of gonadectomy and estrogen treatment.
Juni A; Klein G; Kowalczyk B; Ragnauth A; Kest B
Neuropharmacology; 2008 Jun; 54(8):1264-70. PubMed ID: 18457849
[TBL] [Abstract][Full Text] [Related]
27. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
[TBL] [Abstract][Full Text] [Related]
28. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614.
Tiseo PJ; Inturrisi CE
J Pharmacol Exp Ther; 1993 Mar; 264(3):1090-6. PubMed ID: 8450453
[TBL] [Abstract][Full Text] [Related]
29. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
Dunbar SA; Karamian I; Zhang J
Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
[TBL] [Abstract][Full Text] [Related]
30. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo.
Gilbert ME; Lasley SM
Neurotoxicol Teratol; 2007; 29(3):385-93. PubMed ID: 17350801
[TBL] [Abstract][Full Text] [Related]
31. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
32. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
Craft RM; Lee DA
Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
[TBL] [Abstract][Full Text] [Related]
33. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
34. Mechanical pain hypersensitivity after incisional surgery is enhanced in rats subjected to neonatal peripheral inflammation: effects of N-methyl-D-aspartate receptor antagonists.
Chu YC; Chan KH; Tsou MY; Lin SM; Hsieh YC; Tao YX
Anesthesiology; 2007 Jun; 106(6):1204-12. PubMed ID: 17525596
[TBL] [Abstract][Full Text] [Related]
35. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
[TBL] [Abstract][Full Text] [Related]
36. The NMDA receptor antagonist MK-801 protects against the development of morphine tolerance after intrathecal administration.
Kest B; Mogil JS; Shamgar BE; Kao B; Liebeskind JC; Marek P
Proc West Pharmacol Soc; 1993; 36():307-10. PubMed ID: 8378393
[No Abstract] [Full Text] [Related]
37. Co-administration of MK-801 and morphine attenuates neuropathic pain in rat.
Hamidi GA; Manaheji H; Janahmadi M; Noorbakhsh SM; Salami M
Physiol Behav; 2006 Jul; 88(4-5):628-35. PubMed ID: 16815501
[TBL] [Abstract][Full Text] [Related]
38. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
[TBL] [Abstract][Full Text] [Related]
39. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
[TBL] [Abstract][Full Text] [Related]
40. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine.
Koyuncuoglu H; Nurten A; Yamantürk P; Nurten R
Pharmacol Res; 1999 Apr; 39(4):311-9. PubMed ID: 10208762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
